Publication | Closed Access
Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice
19
Citations
42
References
2022
Year
InflammationFibrosisGastrointestinal PharmacologyLiver PhysiologyMedicineImmunologyTgfβ1/smad PathwayPathologyHepatotoxicityPharmacotherapyCholangiopathiesPharmacologyCell SignalingHepatic Erk/-egr-1 SignalingDrug-induced Liver InjuryDigestive System Diseases
| Year | Citations | |
|---|---|---|
Page 1
Page 1